Trials / Completed
CompletedNCT02590939
Acute Treatment of Migraine With e-TNS
Multi-center, Double-blind, Randomized, Sham-controlled Trial on the Acute Treatment of Migraine With the Cefaly® Device
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 106 (actual)
- Sponsor
- Cefaly Technology · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this study is to assess the efficacy of the Cefaly® device as an acute treatment of migraine attack in adult patients. The patients will be applied either an active or placebo external neurostimulation for 1 hour during a migraine attack, and will report the pain on a visual analog scale before and after the treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CEFALY Active | Active external trigeminal nerve stimulation |
| DEVICE | CEFALY Placebo | Placebo external trigeminal nerve stimulation |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2017-03-31
- Completion
- 2017-03-31
- First posted
- 2015-10-29
- Last updated
- 2018-06-06
- Results posted
- 2018-04-09
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02590939. Inclusion in this directory is not an endorsement.